English | Español

Community
+ Community
Nicholas Gueguen | Aug 22, 2017

The Medicines Company releases progress report for second quarter
+ Community
Kacie Whaley | Aug 19, 2017

AAFP Foundation awards $3,000 scholarships to three project graduates
+ Community
Kacie Whaley | Aug 19, 2017

CDC and FDA announce recall of stool softeners
+ Community
Nicholas Gueguen | Aug 19, 2017

Abbott extends offer to buy Alere stock
+ Community
Mia Sims | Aug 18, 2017

Study finds rate of ACL tears in teenage females is rising
+ Community
Nicholas Gueguen | Aug 17, 2017

ALS Association initiative getting a Major League Baseball boost
+ Community
Carol Ostrow | Aug 17, 2017

Abbott, North West London Pathology agree to diagnostic products deal
+ Community
Nicholas Gueguen | Aug 17, 2017

Study indicates nutrition plans can benefit hospitals, patients

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes